National Health Company Top Insiders
NHI Stock | USD 74.70 1.36 1.85% |
National Health employs about 30 people. The company is managed by 18 executives with a total tenure of roughly 157 years, averaging almost 8.0 years of service per executive, having 1.67 employees per reported executive. Assessment of National Health's management performance can provide insight into the firm performance.
Eric Mendelsohn CEO CEO President |
John Spaid President Chief Financial Officer, Executive Vice President - Finance |
National |
National Health's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with National Health's future performance. Based on our forecasts, it is anticipated that National will maintain a workforce of under 30 employees by April 2025.National Health Management Team Effectiveness
The company has Return on Asset of 0.0463 % which means that on every $100 spent on assets, it made $0.0463 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1028 %, implying that it generated $0.1028 on every 100 dollars invested. National Health's management efficiency ratios could be used to measure how well National Health manages its routine affairs as well as how well it operates its assets and liabilities. As of now, National Health's Return On Tangible Assets are decreasing as compared to previous years. The National Health's current Return On Assets is estimated to increase to 0.08, while Return On Capital Employed is projected to decrease to 0.09. As of now, National Health's Return On Tangible Assets are decreasing as compared to previous years. The National Health's current Debt To Assets is estimated to increase to 0.44, while Total Assets are projected to decrease to under 1.4 B.The National Health's current Net Income Applicable To Common Shares is estimated to increase to about 102.4 M, while Common Stock Shares Outstanding is projected to decrease to under 32.5 M.
National Health Workforce Comparison
National Health Investors is rated below average in number of employees category among its peers. The total workforce of Real Estate industry is now estimated at about 1,663. National Health claims roughly 30.0 in number of employees contributing just under 2% to equities listed under Real Estate industry.
National Health Profit Margins
The company has Net Profit Margin of 0.41 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.63 %, which entails that for every 100 dollars of revenue, it generated $0.63 of operating income.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 1.08 | 1.11 |
|
| |||||
Net Profit Margin | 0.44 | 0.5363 |
|
| |||||
Operating Profit Margin | 0.7 | 0.8356 |
|
| |||||
Pretax Profit Margin | 0.67 | 0.5363 |
|
| |||||
Return On Assets | 0.0814 | 0.0527 |
|
| |||||
Return On Equity | 0.0958 | 0.1009 |
|
|
National Health Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific National Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on National Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, National Health insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2025-03-01 | 8.5 | 17 | 2 | 171,167 | 534.00 |
2024-09-01 | 1.0909 | 48 | 44 | 719,966 | 1,029,136 |
2024-06-01 | 1.0 | 1 | 1 | 437.00 | 230.00 |
2022-09-01 | 0.6667 | 2 | 3 | 19,833 | 52,731 |
2022-06-01 | 2.0 | 2 | 1 | 50,000 | 0.00 |
2021-09-01 | 10.0 | 10 | 1 | 10,468 | 45,307 |
2021-03-01 | 5.6667 | 17 | 3 | 386,669 | 49,844 |
2020-03-01 | 1.25 | 35 | 28 | 699,625 | 661,150 |
2019-12-01 | 0.3333 | 1 | 3 | 16,668 | 31,886 |
2019-09-01 | 0.2 | 1 | 5 | 16,666 | 34,061 |
2019-03-01 | 1.1852 | 32 | 27 | 650,001 | 645,026 |
2018-12-01 | 0.6667 | 8 | 12 | 158,332 | 261,454 |
2018-09-01 | 0.625 | 5 | 8 | 90,000 | 149,494 |
2018-06-01 | 1.0 | 4 | 4 | 54,453 | 88,548 |
2017-12-01 | 1.0 | 1 | 1 | 263.00 | 0.00 |
2017-09-01 | 0.5 | 5 | 10 | 66,925 | 126,583 |
2017-06-01 | 0.5 | 2 | 4 | 29,166 | 54,833 |
2017-03-01 | 10.0 | 20 | 2 | 385,000 | 24,593 |
2016-09-01 | 0.6154 | 8 | 13 | 126,664 | 217,084 |
2016-06-01 | 0.5926 | 16 | 27 | 270,001 | 460,081 |
2016-03-01 | 2.0 | 18 | 9 | 315,002 | 169,218 |
2015-12-01 | 2.0 | 4 | 2 | 17,833 | 29,787 |
2015-03-01 | 1.037 | 28 | 27 | 658,734 | 641,782 |
2014-03-01 | 10.0 | 10 | 1 | 226,858 | 400.00 |
2013-03-01 | 5.5 | 11 | 2 | 231,668 | 9,909 |
2012-12-01 | 0.35 | 7 | 20 | 125,000 | 239,601 |
2012-09-01 | 0.5 | 5 | 10 | 116,665 | 214,395 |
2012-06-01 | 0.3 | 6 | 20 | 155,000 | 339,768 |
2012-03-01 | 0.9412 | 16 | 17 | 365,835 | 259,201 |
2011-12-01 | 0.3 | 3 | 10 | 35,834 | 60,407 |
2011-09-01 | 0.8182 | 9 | 11 | 112,500 | 180,678 |
2011-03-01 | 1.5 | 12 | 8 | 248,333 | 68,384 |
2010-09-01 | 0.5 | 4 | 8 | 88,333 | 157,451 |
2010-06-01 | 0.5 | 10 | 20 | 114,330 | 202,901 |
2010-03-01 | 1.6 | 16 | 10 | 410,834 | 85,129 |
2009-12-01 | 0.2143 | 3 | 14 | 100,030 | 367,617 |
2009-09-01 | 0.3636 | 4 | 11 | 39,166 | 98,017 |
2009-06-01 | 0.5 | 1 | 2 | 15,000 | 27,219 |
2009-03-01 | 8.0 | 8 | 1 | 198,334 | 3,000 |
2008-09-01 | 0.6 | 3 | 5 | 14,343 | 70,000 |
2008-06-01 | 2.5 | 5 | 2 | 64,771 | 48,333 |
2008-03-01 | 0.9286 | 13 | 14 | 159,186 | 199,860 |
2007-06-01 | 5.0 | 5 | 1 | 75,000 | 725.00 |
2006-06-01 | 2.5 | 5 | 2 | 75,000 | 30,000 |
2005-12-01 | 1.0 | 1 | 1 | 15,000 | 15,000 |
2005-03-01 | 1.375 | 11 | 8 | 154,721 | 100,521 |
2004-12-01 | 0.5455 | 6 | 11 | 41,375 | 41,375 |
2004-06-01 | 1.5 | 9 | 6 | 116,000 | 72,860 |
2003-12-01 | 0.5 | 2 | 4 | 54,617 | 143,234 |
2003-09-01 | 0.8 | 4 | 5 | 107,750 | 113,350 |
National Health Notable Stakeholders
A National Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as National Health often face trade-offs trying to please all of them. National Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting National Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Eric Mendelsohn | CEO President | Profile | |
John Spaid | Chief Financial Officer, Executive Vice President - Finance | Profile | |
D Mendelsohn | Executive Vice President - Corporate Finance | Profile | |
Kevin Pascoe | Executive VP of Investments | Profile | |
Robert Adams | Independent Director | Profile | |
James Jobe | Independent Director | Profile | |
Robert Webb | Independent Director | Profile | |
Dana Hambly | Director of Investor Relations | Profile | |
Robert McCabe | Independent Director | Profile | |
Kimberly Ouimet | Director Resources | Profile | |
Colleen Schaller | Director of Investor Relations | Profile | |
Charlotte Swafford | Independent Director | Profile | |
David Travis | Senior Vice President Chief Accounting Officer | Profile | |
Beth Blankenship | Senior Affairs | Profile | |
W Adams | Independent Chairman of the Board | Profile | |
Michelle Kelly | Senior Investments | Profile | |
Susan Sidwell | Corporate Secretary | Profile | |
Kristin Gaines | Chief Credit Officer | Profile |
About National Health Management Performance
The success or failure of an entity such as National Health Investors often depends on how effective the management is. National Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of National management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the National management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.05 | 0.08 | |
Return On Capital Employed | 0.10 | 0.09 | |
Return On Assets | 0.05 | 0.08 | |
Return On Equity | 0.10 | 0.10 |
National Health Workforce Analysis
Traditionally, organizations such as National Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare National Health within its industry.National Health Manpower Efficiency
Return on National Health Manpower
Revenue Per Employee | 8.6M | |
Revenue Per Executive | 14.3M | |
Net Income Per Employee | 4.6M | |
Net Income Per Executive | 7.6M |
Complementary Tools for National Stock analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |